<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2011-128</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-67</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GUIDELINES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ</subject></subj-group></article-categories><title-group><article-title>International recommendations for the secondary prevention of ischemic stroke and their realization in outpatient practice</article-title><trans-title-group xml:lang="ru"><trans-title>Международные рекомендации по вторичной профилактике ишемического инсульта и их реализация в амбулаторной практике</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парфенов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Parfenov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">vladimirparfenov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вербицкая</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Verbitskaya</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><email xlink:type="simple">info@ima-press.net</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Первый МГМУ им. И.М. Сеченова</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>поликлиника №151</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>16</day><month>03</month><year>2011</year></pub-date><volume>3</volume><issue>1</issue><issue-title>NO1 (2011)</issue-title><fpage>16</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Parfenov V.A., Verbitskaya S.V., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Парфенов В.А., Вербицкая С.В.</copyright-holder><copyright-holder xml:lang="en">Parfenov V.A., Verbitskaya S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/67">https://nnp.ima-press.net/nnp/article/view/67</self-uri><trans-abstract xml:lang="ru"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Sacco R. L., Adams R., Albers G. et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.&lt;/p&gt;&lt;p&gt;Вербицкая С.В., Парфенов В.А. Вторичная профилактика инсульта в амбулаторных условиях. Неврол журн 2011 (в печати).&lt;/p&gt;&lt;p&gt;Rashid P. , Leonardi-Bee J., Bath P. P. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events. Stroke 2003;34:2741-8.&lt;/p&gt;&lt;p&gt;Rothwell P.M., Howard S.C., Spence J.D. for the Carotide Endarterectomy Trialist`s Collaboration. Relationship between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease. Stroke 2003;34:2583-92.&lt;/p&gt;&lt;p&gt;Schrader J., Luders S., Kulschewski A. et al. Mortality and morbidity after stroke, Eprosartan compared with Nitrendipine for secondary prevention. Principal results of a prospective randomised controlled study (MOSES). Stroke 2005;36:1218-26.&lt;/p&gt;&lt;p&gt;Haas W.K., Easton J.D., Adams H.Р. et al. A randomized trial comparing ticlopedine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989;329:501-7.&lt;/p&gt;&lt;p&gt;Gorelick P.B., Richardson D., Kelly M. for the African American Antiplatelet Stroke Prevention Study Investigators. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003;289:2947-57.&lt;/p&gt;&lt;p&gt;Bhatt D., Fox K., Hacke W. et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.&lt;/p&gt;&lt;p&gt;Diener H., Bogousslavsky J., Brass L. et al. Acetylsalicylic acid on a background of clopidogrel in high-risk patients randomised after recent ischaemic stroke or transient ischaemic attack: the MATCH trial results. Lancet 2004;364:331-4.&lt;/p&gt;&lt;p&gt;Diener H.C., Cunha L., Forbes C. et al. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.&lt;/p&gt;&lt;p&gt;Connolly S., Ezekowitz M.D., Ysuf S. et al. Dabigatran versus warfarin in patients with atrial fibrillation (ACTIVE A). N Engl J Med 2009;361:1139-51.&lt;/p&gt;&lt;p&gt;Amarenco P. , Bogousslavsky J., Amarenco P. et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.&lt;/p&gt;&lt;p&gt;Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-53.&lt;/p&gt;&lt;p&gt;Rothwell P.M., Eliasziw M., Gutnikov S.A. et al. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-24.&lt;/p&gt;&lt;p&gt;Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial: the EC/IC Bypass Study Group. N Engl J Med 1985;313:1191-200.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Sacco R. L., Adams R., Albers G. et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.&lt;/p&gt;&lt;p&gt;Вербицкая С.В., Парфенов В.А. Вторичная профилактика инсульта в амбулаторных условиях. Неврол журн 2011 (в печати).&lt;/p&gt;&lt;p&gt;Rashid P. , Leonardi-Bee J., Bath P. P. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events. Stroke 2003;34:2741-8.&lt;/p&gt;&lt;p&gt;Rothwell P.M., Howard S.C., Spence J.D. for the Carotide Endarterectomy Trialist`s Collaboration. Relationship between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease. Stroke 2003;34:2583-92.&lt;/p&gt;&lt;p&gt;Schrader J., Luders S., Kulschewski A. et al. Mortality and morbidity after stroke, Eprosartan compared with Nitrendipine for secondary prevention. Principal results of a prospective randomised controlled study (MOSES). Stroke 2005;36:1218-26.&lt;/p&gt;&lt;p&gt;Haas W.K., Easton J.D., Adams H.Р. et al. A randomized trial comparing ticlopedine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989;329:501-7.&lt;/p&gt;&lt;p&gt;Gorelick P.B., Richardson D., Kelly M. for the African American Antiplatelet Stroke Prevention Study Investigators. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003;289:2947-57.&lt;/p&gt;&lt;p&gt;Bhatt D., Fox K., Hacke W. et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.&lt;/p&gt;&lt;p&gt;Diener H., Bogousslavsky J., Brass L. et al. Acetylsalicylic acid on a background of clopidogrel in high-risk patients randomised after recent ischaemic stroke or transient ischaemic attack: the MATCH trial results. Lancet 2004;364:331-4.&lt;/p&gt;&lt;p&gt;Diener H.C., Cunha L., Forbes C. et al. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.&lt;/p&gt;&lt;p&gt;Connolly S., Ezekowitz M.D., Ysuf S. et al. Dabigatran versus warfarin in patients with atrial fibrillation (ACTIVE A). N Engl J Med 2009;361:1139-51.&lt;/p&gt;&lt;p&gt;Amarenco P. , Bogousslavsky J., Amarenco P. et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.&lt;/p&gt;&lt;p&gt;Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-53.&lt;/p&gt;&lt;p&gt;Rothwell P.M., Eliasziw M., Gutnikov S.A. et al. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-24.&lt;/p&gt;&lt;p&gt;Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial: the EC/IC Bypass Study Group. N Engl J Med 1985;313:1191-200.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
